Exposure of the American People to Iodine-131 from Nevada Nuclear-Bomb Tests Review of the National Cancer Institute Report and Public Health Implications (1999) / Chapter Skim
Currently Skimming:
Appendix A. Study Activities
Appendix A. Study Activities
Pages 177-185
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 177... ...
The IOM Committee on Guidelines for Thyroid Cancer Screening after Exposure to Radioactive Iodine Fallout was appointed to focus on clinical and public health issues and policies. It included experts in preventive services, thyroid cancer diagnosis and management, medical decision-making, practice guideline development and implementation, and public health policy.
|
From page 178... ...
In an open session December 19, the NRC committee and observers received some six hours of detailed briefings on the National Cancer Institute Report by the investigators. This began with an Introduction and Overview of the Study by Dr.
|
From page 179... ...
Kymberlee Burnell, a psychotherapist who spoke on her own behalf. The second day focused on continued discussion of the structure of the report, and how best to integrate the work of the IOM committee investigating clinical and public health policies and the results to emerge from the Workshop on Thyroid Cancer Screening and Health Implications of Exposure to Radioactive Iodine Fallout to be held in Washington, D.C.
|
From page 180... ...
Bea Kelleigh, the Executive Director, Cedar River Associates, under contract with the Hanford Health Information Network to develop public information, described at some length the steps that have been and are being taken by the Hanford Health Information Network to inform the public of the findings of the studies associated with the Hanford Nuclear Facility and their public health implications. On March 17, the committee met briefly in closed session in advance of the workshop organized by the IOM committee considering the clinical and public health policy implications of iodine-131 exposure and thyroid cancer risk.
|
From page 181... ...
Preventive Services Task Force Dartmouth-Hitchcock Medical Center Lisa Schwartz, M.D. and Steven Woloshin, M.D., Dartmouth Medical School; Veterans Affairs Outcomes Group White River VAMC David Ransohoff, M.D., University of North Carolina, Chapel Hill Robert Thompson, M.D., Group Health Cooperative of Puget Sound General discussion 4:40 Heuristic Decision Model for Thyroid Cancer Stephen Pauker, M.D., IOM Committee Member New England Medical Center General discussion
|
From page 182... ...
and Richard Reingans, Ph.D., Agency for Toxic Substances and Disease Registry, CDC General discussion 12:00 Lunch 1:15 Continued discussion 2:00 Public Health and Consumer Perspectives Kristine Gebbie, M.D., Former Commissioner of Health, State of Wash ington; Columbia University Morton Rabinowitz, Ph.D., DuPont H Jack Geiger, M.D., City University of New York Medical School Richard Schultz, M.S., Idaho Department of Health and Welfare 3:30 Break 3:45 Public Comment Period 5:45 Adjourn WORKSHOP PARTICIPANTS LIST Keith F
|
From page 183... ...
of Community Health and Social Medicine City University of New York Medical School Paul Gilman, Ph.D. Executive Director Commission on Life Sciences National Research Council/National Academy of Sciences 183 Peter G
|
From page 184... ...
Chairman Center for Demographic and Population Genetics School of Public Health University of Texas Richard H Schultz, M.S.
|
From page 185... ...
Assistant Chief, Department of Clint cat Investigation; Chief, Clinical Studies Service Walter Reed Army Medical Center Samuel A Wells, M.D.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.